LSE:APH (Alliance Pharma plc)

About APH

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of pharmaceutical products. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from Kelo-cote brand. Geographically, it derives a majority of revenue from Europe, Middle East and Africa (EMEA).
  • Alliance Pharma plc (LSE: APH) Latest News

    Investing Articles

    Could this pharma stock help me become an ISA millionaire?

    Roland Head reviews two potential money-makers from the pharma sector. Should you I these in my ISA today?

    Read more »

    Investing Articles

    Could this FTSE 100 stock double your money again?

    G A Chester discusses the outlook for this FTSE 100 (INDEXFTSE:UKX) big winner and a smaller-cap peer.

    Read more »

    Investing Articles

    Have £1,000 to invest? A red-hot dividend growth hero I’d buy and hold for the next decade

    Royston Wild looks a great dividend growth share to snap up today and hold for many years to come.

    Read more »

    Investing Articles

    Should you invest in Mark Slater favourite Alliance Pharma right now?

    I reckon there's a lot to like about the steady growth proposition in Alliance Pharma plc (LON: APH).

    Read more »

    Investing Articles

    2 pharma stocks that could make you a fortune by retirement

    Royston Wild looks at two brilliant pharma selections that could make you a fortune.

    Read more »

    Investing Articles

    2 stocks I’d hold for the next 20 years

    Looking for growth superstars to buy and hold for decades? These two shares could prove just the ticket.

    Read more »

    Investing Articles

    Mark Slater favourite Alliance Pharma plc could make you rich

    We could be seeing decent growth potential at a reasonable price with Alliance Pharma plc (LON: APH).  

    Read more »

    Investing Articles

    2 bargain pharma stocks I’d buy today

    Roland Head highlights two pharmaceutical picks you might not have considered.

    Read more »

    Investing Articles

    2 ‘secret’ pharma stocks I’m considering buying right now

    G A Chester reveals two under-the-radar pharma stocks that could deliver market-trumping returns.

    Read more »

    Investing Articles

    2 top growth stocks for February

    Today I am looking at two growth goliaths investors may wish to buy today.

    Read more »

    Investing Articles

    2 promising small-cap stocks that could be millionaire-makers in 2018

    These two shares could help you to generate high returns.

    Read more »

    Investing Articles

    2 secret growth stocks that could make you a fortune

    Royston Wild looks at two shares with hot earnings potential.

    Read more »